Trial intelligence / Profile preview

Fetal IVIG During Intrauterine Transfusion for Rhesus Isoimmunization

NCT07885592Phase 2Recruiting

Sponsor
Post Graduate Institute of Medical Education and Research
Start
May 2026
Primary completion
Jun 2027
Countries
1
01

Overview

A Phase 2 trial of intravenous immunoglobulin G in Rhesus isoimmunization, anemia, hemolytic disease of the newborn (HDN), sponsored by Post Graduate Institute of Medical Education and Research. Started May 2026; status: recruiting.

02

Drugs

intravenous immunoglobulin G
03

Conditions

Rhesus isoimmunizationanemiahemolytic disease of the newborn (HDN)

Beyond the preview

Go deeper on NCT07885592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07885592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call